Two meta-analyses, which included 12 case-control studies, have shown that TGFBR1*6A is a candidate tumour-susceptibility allele, is present in 13.7% of the general population and increases the risk of cancer by approximately 24% [6,7]. This evidence concerns the gene TGFBR1 and neoplasm.